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EXPERIMENTAL SECTION 
 
Sample Preparation 
Histones from calf thymus were obtained from Roche (Indianapolis, IN, USA). HeLa, Jurkat and 
MCF-7 cells were generously provided from Dr. Raymond J. Deshaies laboratory. Histones from 
HeLa, Jurkat and MCF-7 cells were acid extracted with 0.4 N H2SO4 and precipitated with 30% 
(v/v) trichloroacetic acid as previously described.
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 The histone pellet was dried, resuspended in 
water and protein concentration was determined by Bradford assay (Bio-Rad Laboratories, 
Hercules, CA, USA). For middle-down analysis, 10 μg of unfractionated histones were digested 
either with Glu-C (Roche) at an enzyme to protein ratio of 1:30 in 25 mM NH4HCO3 (pH = 7.8) 
at 25 °C, or, Asp-N at an enzyme to protein ratio of 1:25 in 50 mM NH4HCO3 (pH = 8.0) at 37 
°C. Digestions were performed for 9 to 14 hours. All reactions were quenched with 0.5% formic 
acid. Digested samples were desalted with C18 Ziptips (Millipore, Billerica, MA). Unfractionated 
desalted peptides were lyophilized and stored at -20°C. Prior to LC-ECD-MS/MS analyses, 
digested histone peptides were resuspended in 0.2% formic acid. 
 
Data Analysis 
For peptide and protein identification an in-house developed search engine, ROCCIT, was used. 
ROCCIT is a next generation MS/MS database search engine that can increase the number of 
confident peptide identifications made at a fixed false discovery (FDR) rate by taking advantage 
of the following features. First, ROCCIT uses a novel peptide-spectrum match (PSM) scoring 
metric that is based on a commonly used performance metric in machine learning, the area under 
the ROC curve. This new scoring metric excels at differentiating true matches from false 
matches and is sensitive enough to help localize PTMs. Second, ROCCIT uses a high mass 
accuracy filter to identify matches unlikely to be correct based on precursor mass error alone. 
Thus ROCCIT achieves a high level of sensitivity while maintaining its specificity. Third, 
ROCCIT takes into account known modifications and cleavages when conducting the search by 
encoding modifications such as known phosphorylation sites in Uniprot. This allows for 
identifying modifications and cleavages that are common at a particular position on a particular 
protein but rare in general. Fourth, ROCCIT takes advantage of the MapReduce distributed 
computing framework to allow for massively parallel searches across many computers 
simultaneously. This allows for a greater number of variable modifications to be considered per 
peptide. One additional feature of ROCCIT that was particularly useful to this study was the 
display of search results in an easy to interpret web page. More specifically, each identified PSM 
included a link to the MS-Product function of ProteinProspector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct) to allow 
visualization of each match and, therefore, alternate peptide hypotheses could be explored. 
 
In addition to the variable modifications mentioned in the main manuscript, the data was also 
searched for phosphorylation on Ser, Thr and Tyr. However, no high scoring phosphorylated 
peptides were identified, with the exception of three phosphorylated peptides from H2A 2-C, 
H2A.1 and H1.1 from calf thymus (Supporting Information, Figures S30A and S31D). This is 
presumably due to the fact that no enrichment of phosphorylated peptides was performed in the 
samples. As phosphorylated peptides are of lower abundance, compared to other peptides present 
in the samples, and given that the instrument was operated in data-dependent acquisition mode, 
in which only the most abundant peptides are sequenced, is not very surprising that, in general, 
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phosphorylated peptides were not identified. We should note that the search engine, ROCCIT, 
used for peptide identification will take into consideration known modifications, which are 
already included in Uniprot, even if they are not specified in the search as variable modifications. 
The phosphorylated peptides identified for H2A 2-C, H2A.1 and H1.1 correspond to known 
phosphorylated sites included in Uniprot and as such they were also identified in the search, in 
which phosphorylation was not included as variable modification. 
 
Positional isomers (peptides with the same amino acid sequence that are modified at different 
positions) were identified by manually examining and verifying the ECD spectra for which a 
single precursor ion mass was assigned to more than one modified peptides differing only at the 
position of the modification. 
 
We note that for histone variants sharing the same N-terminal tail it is not feasible to determine, 
with neither the bottom-up nor the middle-down approach, if the identified PTMs are present in 
all variants or only in one specific histone variant. This information can only be revealed by the 
top-down approach.  
 
 
RESULTS AND DISCUSSION  
 
Optimization of middle-down nano-LC-ECD MS/MS 
 
Figure S1 displays the results obtained from an in silico digest of bovine and human histones. 
Bovine and human histones sequences were obtained from UniProt (containing 55 and 105 
sequences for bovine and human, respectively), and an in silico digest was performed with 
trypsin, Lys-C, Arg-C, Glu-C, and Asp-N to calculate the theoretical number of proteolytic 
peptides produced by each enzyme.  
 
Figure S2 displays the theoretical number of derived proteolytic peptides as a function of the 
peptide mass for trypsin, Lys-C, Arg-C, Glu-C and Asp-N. As illustrated in this Figure, Glu-C 
and Asp-N generate the higher number of peptides in the desirable mass range for middle-down 
analysis of histones. We note that peptides having a mass of ≤ 3000 Da cannot be considered as 
middle-down size peptides; however, they are unavoidable following digestion with any of the 
enzymes examined. A good compromise is to select proteolytic enzymes like Glu-C and Asp-N, 
which produce fewer peptide of this size (Figure S2, inset). 
 
Figures S3 to S9 show representative examples of the effect of electron energy and irradiation 
time on the ECD outcome as a function of the peptide charge state. 
 
 
For several peptides more than one charge state was selected for fragmentation. As the data was 
collected in data-acquisition mode the number of charge states selected for fragmentation per 
peptide was highly dependent on the number of charge states detected per peptide, on the 
abundance of each charge state and also on the abundance of other peptides present in the MS 
spectrum. Under the same ECD conditions (same electron energy and irradiation time), no major 
differences were observed between different charge states. Representative examples of ECD 
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spectra of peptides fragmented in two different charge states are shown in Figures S10 to 
S17.Although some product ions are unique for each charge state, the total number of product 
ions and the peptide sequence coverage obtained is very similar or identical between different 
charge states. This is mainly due to the fact that the vast majority of peptides subjected to ECD 
was highly charged and therefore fragment efficiently in ECD. This is in accordance with 
previously published data
2
 in which it was shown that peptides with m/z < 950 fragment 
efficiently in ECD and that high peptide sequence coverage is obtained in ECD of highly 
charged precursor ions.  
 
It is worth pointing out that data from histone H3 is fairly low. This is a result of the unspecific 
cleavages we observed for Glu-C. When a search was performed without enzyme specificity, we 
have identified several modified peptides from i.e. H3.2 as illustrated in some representatives 
examples in Figure S18.  These observations are in agreement with those of Gupta et al. who 
examine proteases specificity, including Glu-C, and reported unspecific cleavage sites.
3
 Since in 
our identifications we consider only peptides resulting from specific enzymatic cleavages and 
given that for H3 we mainly observed unspecific Glu-C cleavages the data from H3 was low.  
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FIGURES AND TABLES  
 
 
Figure S1. Number of peptides produced by in silico digests of bovine (A) and human (B) 
histones for different proteolytic enzymes assuming zero missed cleavages.  Data was 
constructed from bovine and humans histone sequences obtained from UniProt (containing 55 
sequences for bovine and 105 sequences for human).  
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Figure S2. Number of peptides as a function of peptide mass produced by in silico digestions of 
bovine (A) and human (B) histones with different proteolytic enzymes assuming zero missed 
cleavages. Data was constructed from bovine and humans histone sequences obtained from 
UniProt (containing 55 sequences for bovine and 105 sequences for human).  
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Figure S3. ECD spectra acquired at different electron energies for the [M + 9H]
9+ 
precursor ions 
of the peptide 65-120 (6.3 KDa) from histone H2A 2-C (and/or H2A 1-H, H2A 1-D). The 
peptide was successfully identified at both electron energies, however, a significantly higher 
number of c- and z-type product ions was observed at lower electron energy (A). The peptide 
was derived from a Glu-C digest of histones extracted from Jurkat cells. Deconvoluted spectra 
are displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S4. ECD spectra acquired at different electron energies for the [M + 7H]
7+ 
precursor ions 
of the peptide 35-92 (6.6 KDa) from histone H2B 1-K (and/or H2B 2-7, H2B 1-H, H2B 1-
C/E/F/G/I). A higher number of c- and z-type product ions was observed at the lower electron 
energy setting (A) resulting in a higher peptide score and a more confident identification. The 
peptide was derived from a Glu-C digest of histones extracted from Jurkat cells. Deconvoluted 
spectra are displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S5. ECD spectra acquired at different electron energies for the [M + 4H]
4+ 
precursor ions 
of the peptide 72-89 (2.3 KDa) from histone H2A 2-B. An almost identical number of c- and z-
type product ions was observed at both experimental conditions, but the intensity of the product 
ions was significantly improved at higher electron energies (A) resulting in a more confident 
peptide identification. The peptide was derived from Asp-N digestion of histones extracted from 
HeLa cells. Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S6. ECD spectra acquired at different electron energies for the [M + 10H]
10+ 
precursor 
ions of the peptide 69-125 (6.4 KDa) from histone H2B 2-E (and/or H2B 1-O, H2B 1-H, H2B 1-
D, H2B 2-F, H2B 1-C/E/F/G/I). The peptide sequence coverage obtained was highly dependent 
on the ECD settings (electron energy and irradiation time) employed, with the lower electron 
energy and lower irradiation time (A) resulting in 32 more c- and z-type product ions. The 
peptide was derived from an Asp-N digestion of histones extracted from HeLa cells. 
Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S7. ECD spectra acquired at different electron energies for the [M + 8H]
8+ 
precursor ions 
of the peptide 1-41 (4.5 KDa) from histone H2A 1-C (and/or H2A 2-C, H2A 2-B). Although an 
almost identical number of c- and z-type product ions was observed with both settings, a higher 
score was obtained for spectrum (B) due to the higher product ion intensity. The peptide was 
derived from a Glu-C digest of histones extracted from MCF-7 cells. Deconvoluted spectra are 
displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S8. ECD spectra acquired at different electron energies for the [M + 6H]
6+ 
precursor ions 
of the peptide 1-41(4.5 KDa) from histone H2A 1-D (and/or H2A 1-B/E). A higher quality ECD 
spectrum was obtained with the experimental settings shown in (A), resulting in higher score and 
more confident peptide identification. The peptide was derived from a Glu-C digest of histones 
extracted from MCF-7 cells. Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S9. ECD spectra acquired at different electron energies for the [M + 10H]
10+ 
precursor 
ions of the peptide 1-69 (6.9 KDa) from histone H1.1. A noticeably higher number of c- and z-
type product ions was observed at the lower electron energy setting (A), resulting in higher 
peptide sequence coverage. The peptide was derived from an Asp-N digestion of histones from 
calf thymus. Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S10. ECD spectra of the [M + 6H]
6+
 (A) and [M + 5H]
5+
 (B) precursor ions of the peptide 
90-130 from histone H2A 2-B.Very similar ECD fragmentation was observed between the two 
charge states. For the ECD experiments the electron energy was set at 1.21 eV and the irradiation 
time at 50 ms. The peptide was derived from an Asp-N digestion of histones from Jurkat cells. 
Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
 
 
 
15 
 
 
Figure S11. ECD spectra of the [M + 10H]
10+
 (A) and [M + 7H]
7+
 (B) precursor ions of the 
peptide 65-121 from histone H2A 2-C (and/or H2A 1-H, H2A 1-D). ECD of the [M + 10H]
10+
 
and [M + 7H]
7+
 precursor ions resulted in the formation of 42 and 44 product ions, respectively. 
For the ECD experiments the electron energy was set at 0.71 eV and the irradiation time at 50 
ms. The peptide was derived from a Glu-C digest of histones from Jurkat cells. Deconvoluted 
spectra are displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S12. ECD spectra of the [M + 8H]
8+
 (A) and [M + 7H]
7+
 (B) precursor ions of the peptide 
24-67 from histone H4. Similar ECD spectra were obtained and the total number of product ions 
is identical for both charge states. For the ECD experiments the electron energy was set at 0.71 
eV and the irradiation time at 50 ms. The peptide was derived from an Asp-N digestion of 
histones from Jurkat cells. Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S13. ECD spectra of the [M + 6H]
6+
 (A) and [M + 5H]
5+
 (B) precursor ions of the peptide 
90-130 from histone H2A 1-B/E (and/or H2A.3). Some product ions were unique for each charge 
state but the ECD peptide sequence coverage was very similar between the two charge states. For 
the ECD experiments the electron energy was set at 0.71 eV and the irradiation time at 50 ms. 
The peptide was derived from an Asp-N digestion of histones from Jurkat cells. Deconvoluted 
spectra are displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S14. ECD spectra of the [M + 9H]
9+
 (A) and [M + 7H]
7+
 (B) precursor ions of the peptide 
1-53 from histone H4. Four more product ions were detected for the [M + 9H]
9+
 precursor ions, 
but, overall extensive ECD fragmentation is obtained from both charge states. For the ECD 
experiments the electron energy was set at 0.21 eV and the irradiation time at 50 ms. The peptide 
was derived from a Glu-C digestion of histones from Jurkat cells. Deconvoluted spectra are 
displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S15. ECD spectra of the [M + 8H]
8+
 (A) and [M + 7H]
7+
 (B) precursor ions of the peptide 
36-93 from histone H2B 1-C/E/F/G/I (and/or H2B 1-K, H2B 1-M, H2B 2-F, H2B 1-H). Overall, 
similar ECD fragmentation was observed. For the ECD experiments the electron energy was set 
at 0.75 eV and the irradiation time at 50 ms. The peptide was derived from a Glu-C digestion of 
histones from MCF-7 cells. Deconvoluted spectra are displayed using Protein Prospector 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S16. ECD spectra of the [M + 8H]
8+
 (A) and [M + 7H]
7+
 (B) precursor ions of the peptide 
36-93 from histone H2B 2-F. Very similar ECD spectra were obtained resulting in the formation 
of 29 and 31 product ions for the M + 8H]
8+
 and [M + 7H]
7+
 precursor ions, respectively. For the 
ECD experiments the electron energy was set at 0.75 eV and the irradiation time at 50 ms. The 
peptide was derived from a Glu-C digestion of histones from MCF-7 cells. Deconvoluted spectra 
are displayed using Protein Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct).  
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Figure S17. ECD spectra of the [M + 9H]
9+
 (A) and [M + 7H]
7+
 (B) precursor ions of the peptide 
1-53 from histone H4. Very similar ECD spectra were obtained resulting in the formation of an 
identical number of c- and z- type product ions. For the ECD experiments the electron energy 
was set at 0.75 eV and the irradiation time at 50 ms. The peptide was derived from a Glu-C 
digestion of histones from MCF-7 cells. Deconvoluted spectra are displayed using Protein 
Prospector (http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msproduct).  
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Figure S18. Peptides from H3.2 (Jurkat cells) corresponding to Glu-C unspecific cleavages. The 
unspecific cleavage sites are indicated in red in the peptide sequence.  
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Figure S19. Experimental outline. 
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Figure S20. Percentage of identified peptides as a function of mass distribution for Glu-C (A) 
and Asp-N (B) derived peptides. Identified peptides from all samples examined (calf thymus, 
HeLa, Jurkat and MCF-7 cells) are summed and displayed together for each protease. As 
illustrated in the figure, the vast majority of the identified peptides had a mass greater than 3 
kDa. 
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Figure S21. ECD spectrum of the peptide 90-130 (4.3 kDa) from histone H2A type 2-A (and/or 
H2A.1). Extensive ECD fragmentation was observed by data dependent middle-down LC-ECD 
MS/MS resulting in 77% peptide sequence coverage. The peptide was derived from Asp-N 
digestion of histones extracted from Jurkat cells. Only the major peaks are labeled in the figure.  
@
 = charge-reduced species and neutral or side chain losses 
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Figure S22. Sequence alignment for human histones H2A 2-A and H2A.1. Amino acid sequence 
differences are indicated in red. These two histones variants differ only at amino acids at 
positions 16 and 51. Peptides 1-71, 72-89 and 90-130 were all detected and fragmented by data-
dependent ECD, resulting in complete protein sequence coverage for both variants. Peptides 72-
89 and 90-130 are shared between H2A type 2-A and H2A type 1 and, therefore do not allow 
differentiation between these two variants. However, the detection and identification of peptide 
1-71 (underlined in the figure) from H2A 2-A and H2A.1 enabled differentiation and assignment 
of both histone variants. The ECD spectrum of peptide 90-130 is shown in Figure S21.The ECD 
spectra of peptide 1-71 from H2A 2-A and H2A.1 are displayed in Figure S23. 
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Figure S23. Data-dependent ECD of peptide 1-71 from H2A.1 (A) and H2A 2-A (B). The 
peptide sequences are shown in Figure S22. Only the major peaks are labeled in the figure. 
@
 = charge-reduced species and neutral or side chain losses. 
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Figure S24A. Peptides identified and PTM combinations observed for H2A 1-H (A), H2A 1-B 
(B), H2A 1-D (C), H2A 2-B (D), H2A 2-C (E), and H2A.3 (F) from Jurkat cells. Peptides were 
derived from Glu-C digestion. 
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Figure S24B. Peptides identified and PTM combinations observed for H2A (A), H2A.x (B), 
H2A.Z (C) from Jurkat cells. Peptides were derived from Glu-C digestion. 
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Figure S24C. Peptides identified and PTM combinations observed for H2B 1-C/E/F/G/I (A), 
H2B 1-J (B), H2AB 1-K (C) and H2B 2-E (D) from Jurkat cells. Peptides were derived from 
Glu-C digestion. 
 
32 
 
Figure S24D. Peptides identified and PTM combinations observed for H2B 1-H (A), H2B 1-O 
(B), H2B 2-F (C) and H2B 3-B (D) from Jurkat cells. Peptides were derived from Glu-C 
digestion. 
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Figure S24E. Peptides identified and PTM combinations observed for H1.x (A), H1.2 (B), H1.3 
(C), and H1.4 (D) and H1.5 (E) from Jurkat cells. Peptides were derived from Glu-C digestion. 
 
34 
 
Figure S24F. Peptides identified and PTM combinations observed for H4 (A) and H3.2 (B)  
from Jurkat cells. Peptides were derived from Glu-C digestion. 
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Figure S25A. Peptides identified and PTM combinations observed for H2A.1 (A), H2A 1-C (B), 
H2A 2-B (C), H2A 1-H (D), H2A 1-J (E) H2A 2-A (F) and H2A 2-C (G) from Jurkat cells. 
Peptides were derived from Asp-N digestion. 
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Figure S25B. Peptides identified and PTM combinations observed for H2A 1-B/E (A), H2A.3 
(B), H2A (C), H2A.x (D) and H2A.Z 2-A (E) from Jurkat cells. Peptides were derived from Asp-
N digestion. 
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Figure S25C. Peptides identified and PTM combinations observed for H2B 1-C/E/F/G/I (A), 
H2B 1-J (B), H2B 1-K (C), H2B 2-E (D), H2B 1-H (E) and H2B 1-O (F) from Jurkat cells. 
Peptides were derived from Asp-N digestion. 
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Figure S25D. Peptides identified and PTM combinations observed for H2B 1-B (A), H2B 1-N 
(B), H2B 1-L (C) and H2B 3-B from Jurkat cells. Peptides were derived from Asp-N digestion. 
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Figure S25E. Peptides identified and PTM combinations observed for H1.x (A), H1.0 (B), H1.2 
(C), H1.3 (D) and H1.4 (E) from Jurkat cells. Peptides were derived from Asp-N digestion. 
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Figure S25F. Peptides identified and PTM combinations observed for H4 (A) and H3.2 (B) from 
Jurkat cells. Peptides were derived from Asp-N digestion. 
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Figure S26A. Peptides identified and PTM combinations observed for H2A 2-C (A), H2A 1-C 
(B), H2A 2-B (C), H2A 1-D (D) and  H2A 1-H (E) from HeLa cells. Peptides were derived from 
Glu-C digestion. 
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Figure S26B. Peptides identified and PTMs combinations observed for H2A 1-B/E (A), H2A.3 
(B),  H2A.x (C), H2A (D) and  H2A.Z (E) from HeLa cells. Peptides were derived from Glu-C 
digestion. 
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Figure S26C. Peptides identified and PTM combinations observed for H2B 1-C/E/F/G/I (A), 
H2B 1-J (B), H2B 1-K (C), H2B 2-E (D) and H2.B 1-H (E) from HeLa cells. Peptides were 
derived from Glu-C digestion. 
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Figure S26D. Peptides identified and PTM combinations observed for H2B 2-F (A) and H2B 3-
B (B) from HeLa cells. Peptides were derived from Glu-C digestion. 
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Figure S26E. Peptides identified and PTM combinations observed for H1.2 (A), H1.4 (B) and 
H1.5 (C) from HeLa cells. Peptides were derived from Glu-C digestion. 
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Figure S26F. Peptides identified and PTM combinations observed for H4 (A) and H3.2 (B) from 
HeLa cells. Peptides were derived from Glu-C digestion. 
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Figure S27A. Peptides identified and PTM combinations observed for H2A 2-C (A), H2A 2-A 
(B),  H2A.1 (C), H2A 1-H (D),  H2A 1-J (E), H2A 1-C (F) and H2A 2-B (G) from HeLa cells. 
Peptides were derived from Asp-N digestion. 
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Figure S27B. Peptides identified and PTM combinations observed for H2A.x (A), H2A (B) and 
H2A.Z (C) from HeLa cells. Peptides were derived from Asp-N digestion. 
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Figure S27C. Peptides identified and PTM combinations observed for H2B 1-C/E/F/G/I (A), 
H2B 2-E (B), H2B 1-J (C) and H2B 1-K (D) from HeLa cells. Peptides were derived from Asp-
N digestion. 
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Figure S27D. Peptides identified and PTM combinations observed for H2B 1-O (A), H2B 1-H 
(B), H2B 2-F (C) and H2B 3-B (D) from HeLa cells. Peptides were derived from Asp-N 
digestion. 
 
51 
 
Figure S27E. Peptides identified and PTM combinations observed for H1.x (A), H1.2 (B) and 
H1.4 (C) from HeLa cells. Peptides were derived from Asp-N digestion. 
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Figure S27F. Peptides identified and PTM combinations observed for H4 (A) and H3.3 (B) from 
HeLa cells. Peptides were derived from Asp-N digestion. 
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Figure S28A. Peptides identified and PTM combinations observed for H2A 1-H (A), H2A 1-D 
(B), H2A 1-B/E (C), H2A 2-C (D), H2A 1-C (E), H2A 2-B (F) and H2A.3 (G) from MCF-7 
cells. Peptides were derived from Glu-C digestion. 
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Figure S28B. Peptides identified and PTM combinations observed for H2A.x (A), H2A (B) and  
H2A.Z (C) from MCF-7 cells. Peptides were derived from Glu-C digestion. 
 
55 
 
Figure S28C. Peptides identified and PTM combinations observed for H2B 1-M (A), H2B 1-K 
(B), H2B 1-C/E/F/G/I (C), H2B 2-F (D), H2B 1-H (E) and H2B 1-O (F) from MCF-7 cells. 
Peptides were derived from Glu-C digestion. 
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Figure S28D. Peptides identified and PTM combinations observed for H2B 1-J (A), H2B 2-E 
(B) and H2B 3-E (C) from MCF-7 cells. Peptides were derived from Glu-C digestion. 
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Figure S28E. Peptides identified and PTM combinations observed for H1.x (A), H1.0 (B), H1.2 
(C), H1.3 (D), H1.4 (E) and H1.5 (F) from MCF-7 cells. Peptides were derived from Glu-C 
digestion. 
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Figure S28F. Peptides identified and PTM combinations observed for H3.2 (A) and H3.3 (B) 
from MCF-7 cells. Peptides were derived from Glu-C digestion. 
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Figure S29A. Peptides identified and PTM combinations observed for H2A 2-A (A), H2A 2-C 
(B), H2A (C), H2A 2-B (D), H2A 1-J (E),  H2A 1-H (F) and H2A 1-C (G) from MCF-7 cells. 
Peptides were derived from Asp-N digestion. 
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Figure S29B. Peptides identified and PTM combinations observed for H2A.x (A) and H2A.Z 
(B) from MCF-7 cells. Peptides were derived from Asp-N digestion 
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Figure S29C. Peptides identified and PTM combinations observed for H2B 2-F (A), H2B 1-
C/E/F/G/I (B), H2B 2-E (C) H2B 1-H (D), H2B 1-N (E) and H2B 1-O (F) from MCF-7 cells. 
Peptides were derived from Asp-N digestion. 
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Figure S29D. Peptides identified and PTM combinations observed for H2B 1-D (A), H2B 1-M 
(B) and H2B 3-B (C) from MCF-7 cells. Peptides were derived from Asp-N digestion. 
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Figure S29E. Peptides identified and PTM combinations observed for H1x (A), H1.0 (B), 
H1.3(C) and H1.4 (D) from MCF-7 cells. Peptides were derived from Asp-N digestion. 
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Figure S29F. Peptides identified and PTM combinations observed for H4 (A) and H3.3 (B) from 
MCF-7 cells. Peptides were derived from Asp-N digestion. 
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Figure S30A. Peptides identified and PTMs combinations observed for H2A 2-C (A), H2A.1 
(B), H2A/A4IFU5 (C), H2A/Q17QG8 (D) and H2A/E1BH22 (E) from calf thymus. Peptides 
were derived from Glu-C digestion. 
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Figure S30B. Peptides identified and PTM combinations observed for H2A/A7E366 (A), H2A.Z 
(B) and H2A.V (C) from calf thymus. Peptides were derived from Glu-C digestion. 
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Figure S30C. Peptides identified and PTM combinations observed for H2B 1-K (A), H2B.1 (B) 
and H2B (C) from calf thymus. Peptides were derived from Glu-C digestion. 
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Figure S30D. Peptides identified and PTM combinations observed for H4 (A), H3.1 (B) and 
H1.3 (C) from calf thymus. Peptides were derived from Glu-C digestion. 
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Figure S31A. Peptides identified and PTM combinations observed for H2A/A4IFU5 (A), H2A.1 
(B), and H2A/E1BDT6 from calf thymus. Peptides were derived from Asp-N digestion. 
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Figure S31B. Peptides identified and PTM combinations observed for H2A/Q17QG8 (A), H2A 
2-C (B), H2A.V (C) and H2A.Z (D) from calf thymus. Peptides were derived from Asp-N 
digestion. 
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Figure S31C. Peptides identified and PTM combinations observed for H2B 1-K (A), H2B.1 (B), 
H2B/A5D7N2 (C) and H2B/E1BGW2 (D) from calf thymus. Peptides were derived from Asp-N 
digestion. 
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Figure S31D. Peptides identified and PTM combinations observed for H4 (A), H3.3 (B), H1.1 
(C), H1.0 (D) and H1.3 (E) from calf thymus. Peptides were derived from Asp-N digestion. 
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Table S1. Electron energies, irradiation times and MS/MS resolution (at m/z 400) employed for 
each sample during nano-LC-ECD-MS/MS. 
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Table S2. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from an Asp-N digested sample of histones extracted from Jurkat cells. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, For= formylation 
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Table S3. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from a Glu-C digested sample of histones extracted from HeLa cells. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, For= formylation 
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Table S4. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from Asp-N digested sample of histones extracted from HeLa cells. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, For= formylation 
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Table S5. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from a Glu-C digested sample of histones extracted from MCF-7cells. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, For= formylation 
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Table S6. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from Asp-N digestion of histones extracted from MCF-7cells. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, For= formylation 
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Table S7. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from Glu-C digestion of histones extracted from calf thymus. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, Ph= phosphorylation 
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Table S8. Summary of identified histone variants, protein sequence coverage obtained, and 
observed PTMs from Asp-N digestion of histones extracted from calf thymus. 
 
Ac= acetylation, Me= methylation, 2Me=dimethylation, Ph= phosphorylation 
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Table S9. Comparison of the middle-down nano-LC ECD MS/MS method presented in this manuscript with previously employed 
methods for histone analysis.
4-10
 
Legend: +++ = very good, ++ = good, + = acceptable, - = average  
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